Perioperative Gabapentin Does Not Reduce Postoperative Delirium in Older Surgical Patients: A Randomized Clinical Trial
Autor: | Leung, Jacqueline M, Sands, Laura P, Chen, Ningning, Ames, Christopher, Berven, Sigurd, Bozic, Kevin, Burch, Shane, Chou, Dean, Covinsky, Kenneth, Deviren, Vedat, Kinjo, Sakura, Kramer, Joel H, Ries, Michael, Tay, Bobby, Vail, Thomas, Weinstein, Philip, Chang, Stacey, Meckler, Gabriela, Newman, Stacey, Tsai, Tiffany, Voss, Vanessa, Youngblom, Emily, Perioperative Medicine Research Group |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
Analgesics Cyclohexanecarboxylic Acids Clinical Trials and Supportive Activities Clinical Sciences Neurosciences Delirium Evaluation of treatments and therapeutic interventions Opioid Length of Stay Perioperative Care Postoperative Complications Double-Blind Method Clinical Research Anesthesiology 6.1 Pharmaceuticals Humans Perioperative Medicine Research Group Female Patient Safety Amines Gabapentin gamma-Aminobutyric Acid Aged |
Zdroj: | Anesthesiology, vol 127, iss 4 |
Popis: | BackgroundPostoperative pain and opioid use are associated with postoperative delirium. We designed a single-center, randomized, placebo-controlled, parallel-arm, double-blinded trial to determine whether perioperative administration of gabapentin reduced postoperative delirium after noncardiac surgery.MethodsPatients were randomly assigned to receive placebo (N = 347) or gabapentin 900 mg (N = 350) administered preoperatively and for the first 3 postoperative days. The primary outcome was postoperative delirium as measured by the Confusion Assessment Method. Secondary outcomes were postoperative pain, opioid use, and length of hospital stay.ResultsData for 697 patients were included, with a mean ± SD age of 72 ± 6 yr. The overall incidence of postoperative delirium in any of the first 3 days was 22.4% (24.0% in the gabapentin and 20.8% in the placebo groups; the difference was 3.20%; 95% CI, 3.22% to 9.72%; P = 0.30). The incidence of delirium did not differ between the two groups when stratified by surgery type, anesthesia type, or preoperative risk status. Gabapentin was shown to be opioid sparing, with lower doses for the intervention group versus the control group. For example, the morphine equivalents for the gabapentin-treated group, median 6.7 mg (25th, 75th quartiles: 1.3, 20.0 mg), versus control group, median 6.7 mg (25th, 75th quartiles: 2.7, 24.8 mg), differed on the first postoperative day (P = 0.04).ConclusionsAlthough postoperative opioid use was reduced, perioperative administration of gabapentin did not result in a reduction of postoperative delirium or hospital length of stay. |
Databáze: | OpenAIRE |
Externí odkaz: |